巨细胞动脉炎与非动脉炎性前部缺血性视神经病变中旁中心急性中层黄斑病变的比较
这项回顾性观察研究比较了活检证实的巨细胞动脉炎(GCA)患者与非动脉炎性前部缺血性视神经病变(NAION)患者中旁中心急性中层黄斑病变(PAMM)的患病率。结果显示PAMM在GCA患者中占28%,在NAION患者中为0%(p<0.001),且PAMM与激素治疗及就诊视力功能无显著关联。PAMM有助于鉴别前部缺血性视神经病变与NAION,并可检测GCA的亚临床视网膜缺血。
要点
- PAMM在GCA患者中患病率为28%,在NAION患者中为0%。
- GCA患者中PAMM与视觉症状状态及激素治疗无显著关联。
- PAMM可用于鉴别前部缺血性视神经病变与NAION。
核心结论
- PAMM在超过四分之一的GCA病例中出现,而在NAION中不出现。
- PAMM在开始皮质激素治疗后仍持续存在,并可检测视觉无症状且视功能正常患者的亚临床视网膜缺血。
研究设计与样本
- 回顾性观察研究,纳入来自两个三级神经眼科诊所的GCA患者(伴或不伴视觉症状)和NAION患者。
- 共纳入80例活检证实的GCA患者和179例NAION患者,收集临床数据、视力(VA)和视野平均偏差(VFMD),回顾OCT图像判断PAMM存在。
主要发现
- PAMM在GCA患者中占28%,在NAION患者中占0%(p<0.001)。
- GCA患者中,PAMM在持续视觉症状者中占33%,一过性症状者中占8%,无视觉症状者中占29%(p=0.23)。
- 在OCT前接受皮质激素治疗的患者中PAMM占29%,未接受者为22%(OR 1.43(95%CI 0.41至4.94);p=0.76)。
- PAMM与就诊时VA或VFMD无显著关联。
临床怎么用
- PAMM可作为鉴别前部缺血性视神经病变与NAION的诊断工具。
- PAMM有助于检测GCA的亚临床眼部受累,即使患者视觉无症状且视功能正常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To compare the prevalence of paracentral acute middle maculopathy (PAMM) on optical coherence tomography (OCT) in patients with giant cell arteritis (GCA) and non-arteritic anterior ischaemic optic neuropathy (NAION) and to evaluate its association with steroid treatment and presenting visual function. METHODS: This retrospective observational study included patients with GCA (with or without visual symptoms) and NAION identified from two tertiary care neuro-ophthalmology practices. Clinical data, visual acuity (VA) and visual field mean deviation (VFMD) were collected. OCT imaging was reviewed for the presence of PAMM. RESULTS: A total of 80 patients with biopsy-proven GCA and 179 patients with NAION were included. PAMM was identified in 28% of patients with GCA versus 0% of patients with NAION (p<0.001). Among patients with GCA, PAMM was observed in 33% of those with persistent visual symptoms, 8% with transient symptoms and 29% without visual symptoms (p=0.23). PAMM was present in 29% of patients who received corticosteroids prior to OCT compared with 22% of those who had not (OR 1.43 (95% CI 0.41 to 4.94); p=0.76). There was no significant association between PAMM and presenting VA or VFMD. CONCLUSIONS: PAMM occurs in over a quarter of GCA cases but not in NAION, persists after initiation of corticosteroid therapy and can detect subclinical retinal ischaemia in visually asymptomatic patients with normal visual function. These findings support the diagnostic utility of PAMM in differentiating between anterior ischaemic optic neuropathy and NAION and detecting GCA with subclinical ocular involvement.
引用
- Hanna A, Dezard V, Namakian S, et al. Paracentral acute middle maculopathy in giant cell arteritis versus non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2026. PMID: 42816146. doi:10.1136/bjo-2026-330414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。